Asia Pacific Pharmaceutical: Internal Control Audit Report
Asia Pacific Pharmaceuticals: Announcement on Proposed Renewal of Accounting Firms
Asia Pacific Pharmaceutical: Special inspection opinions on the 2024 operating income deduction matters of Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Asia Pacific Pharmaceutical: Report on the Work of the Supervisory Committee 2024
Asia Pacific Pharmaceutical: 2024 Annual Audit Report
Asia Pacific Pharmaceutical: Special Instructions on the Use of Annual Funds Raised
Asia Pacific Pharmaceutical: Announcement of Supervisory Committee Resolutions
Asia Pacific Pharmaceutical: Annual Verification Report on the Use of Raised Funds
Asia Pacific Pharmaceuticals: Independent Director\'s Annual Debriefing Report
Asia Pacific Pharmaceuticals: Notice on Changes in Accounting Policies
Asia Pacific Pharmaceutical: Board\'s Special Opinion on Independent Directors\' Independence Assessment
Asia Pacific Pharmaceutical: Announcement on the Company\'s Application for a Comprehensive Credit Line from the Bank
Asia Pacific Pharmaceuticals: Articles of Association
Asia Pacific Pharmaceutical: Announcement of Board Resolutions
Asia Pacific Pharmaceutical: Annual Special Audit Report on Related Party Capital Occupation
Asia Pacific Pharmaceutical: Internal Control Self-Assessment Report
Asia Pacific Pharmaceutical: 2024 Independent Director\'s Debriefing Report (Cai Min)
Asia Pacific Pharmaceutical: 2024 Independent Director\'s Debriefing Report (Liu Yuehui)
Asia Pacific Pharmaceutical: Special Inspection Report of SDIC Securities Co., Ltd. on the storage and use of funds raised by Zhejiang Asia Pacific Pharmaceutical Co., Ltd. in 2024
Asia Pacific Pharmaceutical: Announcement on the company\'s uncovered losses reaching one-third of the total paid-up share capital